Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics
↗
August 14, 2026
Via
Benzinga
Exposures
Product Safety
Bristol Myers Squibb Gets FDA Nod For Novel Multiple Myeloma Treatment
↗
August 14, 2026
Via
Benzinga
Exposures
Product Safety
TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccord
↗
August 14, 2026
Via
MarketBeat
Tickers
HURA
Exposures
Product Safety
Oncobiologics Q3 Earnings Call Highlights
↗
August 14, 2026
Via
MarketBeat
Topics
Earnings
Tickers
AMD
OTLK
Exposures
Financial
Product Safety
NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2
August 14, 2026
Via
Investor Brand Network
Tickers
CSE:QNTM
QNTM
Exposures
Product Safety
Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks
August 14, 2026
Via
Investor Brand Network
Tickers
BMWYY
RGNT
Exposures
Product Safety
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Heart Attack Detection Program, Extends Cash Runway Into 2027
August 14, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
BEAT
Exposures
Intellectual Property
Product Safety
Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval
↗
August 14, 2026
Via
Benzinga
Exposures
Product Safety
NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Advances AI-Driven Oncology Pipeline, Establishes Open Medicine AI
August 14, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Tickers
LTRN
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
Ultrasound Devices Market Size, Trends, and Strategic Outlook 2026-2033
↗
August 14, 2026
Via
Talk Markets
Topics
Economy
Exposures
Product Safety
Supply Chain
Ionis Stock Has Plunged 30%. Is It Time to Buy the Beaten-Down Stock?
↗
August 14, 2026
Via
The Motley Fool
Tickers
ARWR
IONS
Exposures
Product Safety
Amazon Compliant Supplement Manufacturer: Choosing the Right Partner for Your Supplement Brand
↗
August 14, 2026
Via
Talk Markets
Tickers
AMZN
Exposures
Product Safety
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting
↗
August 14, 2026
Via
MarketBeat
Tickers
GRAL
Exposures
Product Safety
Capricor Therapeutics (CAPR) Shares Soar Over 67% After Hours: Here's Why
↗
August 14, 2026
Via
Benzinga
Exposures
Product Safety
1 Surging Stock Worth Your Attention and 2 We Question
August 14, 2026
Via
StockStory
Tickers
DXCM
QRVO
SWK
Exposures
Product Safety
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
↗
August 14, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
CYRX
Exposures
Financial
Product Safety
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript
↗
August 13, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
XAIR
Exposures
Financial
Product Safety
SIGA (SIGA) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
SIGA
Exposures
Financial
Product Safety
Artivion (AORT) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
AORT
Exposures
Financial
Product Safety
iRhythm (IRTC) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
IRTC
Exposures
Financial
Product Safety
Cytosorbents (CTSO) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
CTSO
Exposures
Financial
Product Safety
Capricor Therapeutics Q2 Earnings Call Highlights
↗
August 13, 2026
Via
MarketBeat
Topics
Earnings
Tickers
CAPR
Exposures
Financial
Product Safety
Celcuity Q2 Earnings Call Highlights
↗
August 13, 2026
Via
MarketBeat
Topics
Earnings
Tickers
CELC
Exposures
Financial
Product Safety
Belite Bio Q2 Earnings Call Highlights
↗
August 13, 2026
Via
MarketBeat
Topics
Earnings
Tickers
BLTE
Exposures
Financial
Product Safety
Xenon Pharmaceuticals (XENE) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
XENE
Exposures
Financial
Product Safety
Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026
August 13, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations
August 13, 2026
Via
NewMediaWire
Tickers
FULC
Exposures
Product Safety
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26
August 13, 2026
Via
Newsfile
Tickers
NTHI
Exposures
Product Safety
1Elevan Biopharmaceuticals to Be the Partner of Choice for Peptide Medicine
August 13, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
ADC Therapeutics Q2 Earnings Call Highlights
↗
August 13, 2026
Via
MarketBeat
Topics
Earnings
Tickers
ADCT
Exposures
Financial
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.